A Study of MK-2225 in Healthy Participants (MK-2225-003)

Clinical trial NCT06643390 · COMPLETED

Trial details

NCT number: NCT06643390
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Sclerosis

Start date: 2023-11-21
Primary completion: 2025-07-14
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.